AI-assisted colonoscopy for polyp detection
To Evaluate the Effectiveness and Safety of an Artificial Intelligence-assisted System in Colonoscopy in a Real-world Obsevational Multicenter Study
This study tests whether using artificial intelligence during colonoscopy can help doctors find more polyps in patients getting screened or followed up for colon health.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 7500 (estimated) |
| Ages | 50 Years and up |
| Sex | All |
| Sponsor | Renmin Hospital of Wuhan University Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT06406062 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of an artificial intelligence system in improving the detection rates of adenomas during colonoscopy. It compares polyp detection and adenoma detection rates in multiple centers using AI-assisted colonoscopy versus traditional methods. The study is observational and aims to gather real-world data on the performance of AI in enhancing colonoscopy quality control and polyp detection. Participants will undergo diagnostic, screening, or follow-up colonoscopy as part of the study.
Who should consider this trial
Good fit: Ideal candidates are individuals over 50 years old who require a diagnostic, screening, or follow-up colonoscopy.
Not a fit: Patients with known polyposis syndrome, inflammatory bowel disease, or those deemed unsuitable for colonoscopy may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved detection rates of adenomas, potentially reducing the incidence of colorectal cancer.
How similar studies have performed: Other studies have shown promise in using AI for polyp detection, but the effectiveness of this specific approach remains to be conclusively demonstrated.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age \> 50 years old; 2. required diagnostic colonoscopy, screening colonoscopy, or follow-up colonoscopy; 3. voluntarily sign informed consent; 4. Commitment to abide by the study procedures and cooperate with the implementation of the whole process of the study. Exclusion Criteria: 1. have participated in other clinical trials, signed informed consent and are in the follow-up period of other clinical trials; 2. known polyposis syndrome patients; 3. patients with known IBD; 4. patients considered by the investigators to be unsuitable or unable to undergo complete digestive endoscopy and related examinations; 5. high-risk diseases or other special conditions considered by the investigator to be unsuitable for clinical trial participation.
Where this trial is running
Wuhan, Hubei
- Renmin Hospital of Wuhan Univercity — Wuhan, Hubei, China (Recruiting)
Study contacts
- Study coordinator: Honggang Yu, Doctor
- Email: wjlnsm@163.com
- Phone: 18771146096
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.